Related Experiment Video
Updated: Jun 19, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
PMX-CovEval: A Framework Including a Simulated Pharmacokinetic Database for Covariate Model Building Methods
Mélanie Karlsen1,2, Jérôme Azé1, Sandra Bringay1,3
1LIRMM, Laboratory of Computer Science, Robotics and Microelectronics in Montpellier, CNRS, Montpellier University, Montpellier, France.
A new framework, PMX-CovEval, offers standardized datasets and models for evaluating covariate model building (CMB) methods in population pharmacokinetics (popPK). This resource aids reproducible comparison of CMB strategies for better drug development.
Area of Science:
- Pharmacometrics
- Pharmacokinetics
- Computational Biology
Background:
- Covariate model building (CMB) is crucial in population pharmacokinetics (popPK) for understanding drug variability.
- Existing methods for CMB lack a standardized framework for evaluation and benchmarking.
- This necessitates the development of a unified resource to compare different CMB strategies.
Purpose of the Study:
- Introduce PMX-CovEval, a comprehensive framework for evaluating CMB methods in popPK.
- Provide a standardized and reproducible resource for benchmarking various CMB techniques.
- Facilitate systematic comparison of CMB strategies in real-world pharmacokinetic modeling.
Main Methods:
- Developed PMX-CovEval, a framework comprising 127 diverse scenarios.
- Included pharmacokinetic (PK) datasets, model files for NONMEM and Monolix, and empirical Bayes estimates (EBEs).
- Designed scenarios to reflect real-world complexity while ensuring practical usability.
Main Results:
- PMX-CovEval offers a unified resource with PK datasets, model files, and EBEs.
- The framework supports evaluation of standard CMB techniques available on PsN and Monolix.
- Initial benchmarking results are provided to demonstrate the framework's utility.
Conclusions:
- PMX-CovEval establishes a standardized, reproducible framework for CMB method evaluation in popPK.
- This resource will aid researchers in systematically comparing and selecting optimal CMB strategies.
- The framework promotes advancements in covariate model building for improved pharmacokinetic analyses.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Analysis of Population Pharmacokinetic Data

